Rubio, S. M., Font, M. M., Cordón, L. P., Ulayar, A. S., Bernadas, L. C., Maragall, C. A., . . . Faixo, D. L. (2018). 4CPS-181 Study of the reasons for the therapeutic discontinuation of immune-based therapies in relapsing-remitting multiple sclerosis. Eur J Hosp Pharm.

Rubio, S Marín, M Miarons Font, L Pérez Cordón, A Sanchez Ulayar, L Campins Bernadas, C Agustí Maragall, M Camps Ferrer, T Gurrera Roig, and D Lopez Faixo. "4CPS-181 Study of the Reasons for the Therapeutic Discontinuation of Immune-based Therapies in Relapsing-remitting Multiple Sclerosis." Eur J Hosp Pharm 2018.

Rubio, S Marín, et al. "4CPS-181 Study of the Reasons for the Therapeutic Discontinuation of Immune-based Therapies in Relapsing-remitting Multiple Sclerosis." Eur J Hosp Pharm 2018.